Research at the Heart Transplant Program
UPMC is both a world-class health system and a research powerhouse.
Our academic partner, the University of Pittsburgh, is one of the top 10 institutions in the United States funded by the American Heart Association.
And, the UPMC Heart and Vascular Institute receives millions of dollars in funding each year to conduct cardiovascular research.
Helping More People Benefit from Heart Transplantation
Important areas of research in heart transplantation and ventricular assist device therapy include:
- Less invasive methods of transplant surveillance: Using AlloMap®, which allows physicians to monitor organ rejection via a simple blood sample, rather than a biopsy, we have helped optimize rejection monitoring.
- Improving outcomes for patients with diabetes: Via newer treatment modalities, including the reduced use of steroids, we have achieved outcomes in people with diabetes that are comparable to those without the disease.
- Promoting recovery of heart function while on an LVAD (left ventricular assist device): We have published research on the use of LVADs as a bridge to heart transplant, and even as a potential alternative to transplant (destination therapy).
UPMC also is at the forefront in advances in immunologic studies for the management, reversal, and avoidance of accelerated atherosclerosis.